DeviceTalks Podcast Network

AbbottTalks launches Season 3 with a fresh new video presence, a new co-host, and several new powerful conversations from Abbott's senior leaders. Host Tom Salemi and new co-host Kayleen Brown welcome Vish Charan, divisional vice president of product development for Abbott's Cardiac Rhythm Management, to explore the engineering evolution of the pacemaker—and where it’s headed next. Charan reflects on the remarkable transformation of pacemakers from large, wired implants to compact, leadless systems that dramatically improve patient outcomes. He details Abbott’s development of the AVEIR™ DR dual chamber leadless pacemaker system, the first of its kind to enable synchronized communication between the atrium and ventricle without leads, using Abbott’s proprietary i2i™ (implant-to-implant) technology. The conversation dives deep into conduction system pacing, modular upgrades, and how Abbott is shaping the future of cardiac care for millions of patients. The episode closes with a powerful story of a former professional surfer whose life was transformed by Abbott’s innovation—an example of technology enabling patients to reclaim their lives. Thank you to FPT Americas for sponsoring this episode of AbbottTalks. For more information on how FPT works with medical device companies, visit https://fptsoftware.com/  Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe.

In this debut episode of OlympusTalks, Host Tom Salemi welcomes Olympus Corporation of the Americas’ Vice President of Endoscopy Marketing Kurt Cannon, and colorectal cancer survivor and advocate Brooks Bell for a candid discussion on the importance of early screening. They explore Olympus’ role in advancing endoscopic technology and how it contributes to early detection and prevention of colon cancer.  Bell shares her personal experience with early-onset colorectal cancer, highlighting the urgent need to shift cultural perceptions around colonoscopies. She discusses her work through Worldclass Clothing, a nonprofit aimed at removing barriers to screening. Cannon elaborates on Olympus' commitment to improving adenoma detection rates and sheds light on how their latest innovation, the EVIS X1™ endoscopy system, is designed to support this mission. Colorectal cancer is rising in younger adults—but early screening can make all the difference. Tune in to hear how innovation, advocacy, and awareness are coming together to tackle colorectal cancer.   For more episodes by OlympusTalks, please visit http://olympusamerica.com/podcasts.  *Brooks Bell is a paid endorser of Olympus Corporation, its subsidiaries, and/or its affiliates. **The content of this podcast was paid for by Olympus. ADDITIONAL RESOURCES:  • To learn more about the EVIS X1™ Endoscopy System, visit https://medical.olympusamerica.com/products/evis-x1. • For resources on colorectal cancer screening and to read patient stories, visit https://www.colonoscopytoday.com/.   To follow OlympusTalks on your favorite podcast player and YouTube, please visit: https://olympustalks.castos.com/subscribe  Thank you for listening to the OlympusTalks podcast!

In this episode of Structural Heart Talks, Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, shares how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case. Nuzzolese explains how Edwards takes a "plan, make, source, deliver" approach, and why MedTech supply chains differ from consumer goods with a stronger emphasis on quality and availability. He details how the company strategically leverages dual sourcing, inventory buffering, and global distribution flexibility to maintain operations, even when borders close or suppliers face challenges. He also unpacks the need for automation and digital integration, explains how Edwards connects employees to patient outcomes to instill purpose, and reveals why fostering innovation readiness is central to their long-term strategy. Thank you to Daikin America for sponsoring this episode of Structural Heart Talks. To learn more about Daikin America’s products for your medical application visit https://daikin-america.com. Wait, there’s more! Want to learn more about Daikin America’s new Co-Extrusion technology? Click here for a high resolution image with more detail. Thank you for listening to the Structural Heart Talks podcast.  Subscribe to Structural Heart Talks or the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks on YouTube Podcasts to ensure you never miss an episode.

In this week’s DeviceTalks Podcast, we’re spotlighting two very different leaders shaping the future of surgical robotics. Huge thanks to our sponsor, Murata. First up in our FOMO interview, Tom Salemi speaks with Iman Jeddi, senior vice president and general manager of da Vinci platforms and product operations at Intuitive. Jeddi—who closed out our joint keynotes at DeviceTalks West and RoboBusiness—shares deep insight into Intuitive’s long-term vision and what’s next for the surgical robotics front-runner. Then in our keynote interview, Salemi talked with Anne Osdoit, CEO of Moon Surgical. Osdoit breaks down how the company’s Maestro system—designed to move and stabilize laparoscopic tools—is gaining traction in hospitals and ASCs and carving out a new category in robotic surgery. To learn more about the work Murata is doing in medical devices you can download Murata's Medical Applications Brochure HERE or go to their website murata.com. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of DeviceTalks Weekly, we hear from two of MedTech’s most powerful leaders, each representing different ends of the innovation timeline. Tim Schmid, executive vice president and worldwide chairman of Johnson & Johnson MedTech, lays out the global leaders plan to lead in cardiovascular, surgery, vision, surgical robotics and other high growth businesses. Schmid opened our DeviceTalks West conference last month where he was interviewed by Host Tom Salemi. Thank you to Vantedge Medical for sponsoring this episode. For more information on how Vantedge works with medical device companies, visit: https://vantedgemedical.com/ Then, Josh Makower, the Yock Family Professor and professor of bioengineering at the Stanford Mussallem Center for Biodesign sits down in a FOMO interview with Managing Editor Kayleen Brown. Makower, a battle-tested advocate for MedTech innovators, writes a prescription for helping start-ups, calling on OEMs to provide more support. Makower also keynoted the event. MassDevice editor Chris Newmarker kicks things off with this week’s Newmarker’s Newsmakers – Stryker, Boston Scientific, Siemens Healthineers, Medtronic, Solventum, Abbott and Exact Sciences. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:35) - Stryker VP, GM for Robotics and Enabling Technologies is departing(00:06:16) - Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal(00:08:23) - Do we have bubbles in MedTech?(00:11:26) - Medtronic has a strong Q2 beat on PFA strength(00:16:01) - Solventum to acquire soft tissue repair company Acera Surgical, repurchase $1B in shares(00:18:20) - Abbott confirms plans to acquire Exact Sciences for $21B(00:26:26) - Vantedge Medical – How to Recruit and Retain Talent(00:28:29) - FOMO with Josh Makower - Stanford Mussallem Center for Biodesign(00:37:08) - Vantedge Medical – The importance of metals(00:42:27) - Interview with Tim Schmid, Johnson & Johnson MedTech(00:51:31) - Vantedge Medical – Supply chain concerns

In this episode of Ortho Innovation Talks, host Tom Salemi sits with Brad Batte, President of Enovis™ Regeneration, to discuss how the division is transforming post-operative recovery through bone growth stimulation. He also discusses at-home device compliance, clinical outcomes, and how Enovis is expanding its innovation pipeline to support patients across the full continuum of care. This episode is brought to you by DeviceTalks Tuesdays. Join us for a free week-long webinar series: DeviceTalks "Materials & Manufacturing." *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly podcast, Jian Zheng, founder and CEO of Noah Medical, has found entrepreneurial success in robotics, medical devices and a companies that combine both including Intuitive and Auris. Now, Zheng leads Noah Medical, a robotic bronchoscopy company that’s trying to develop a superior way of diagnosing and treating lung cancer. How does Noah see itself beating Johnson & Johnson MedTech and Intuitive in this competitive space? What areas could Noah focus on next? And where how did the company get the Noah name? Host Tom Salemi asks these questions and more. In this week’s FOMO, Sonia Valdes, vice president of life sciences claims at Medmarc, reveals some of the unseen risks and unintended benefits facing the medical device industry coping with new tariffs on medical device imports. Finally, Chris Newmaker of MassDevice delivers this week’s Newsmakers – Synchron, InBrain, Inspire Medical, Zimmer Biomet, and Olympus. This episode comes to you courtesy of Medmarc. To learn more, visit: https://medmarc.com/ *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:43) - Synchron raises $200M Series D to support BCI commercialization, next-gen tech(00:08:30) - InBrain, Microsoft team up on AI for neurology, BCI tech(00:11:40) - Inspire Medical faces investor class action over Inspire V launch allegations(00:13:28) - Deloitte accuses Zimmer Biomet of filing ‘through the looking glass’ suit(00:16:18) - Olympus to cut 2,000 jobs as it unveils new corporate strategy, executive additions(00:23:45) - FOMO – Sonia Valdes, vice president, life sciences claims, Medmarc(00:35:15) - Keynote Interview – Jian Zhang, CEO, Noah Medical

Artificial Intelligence is transforming healthcare—and Olympus is at the forefront. In this episode, Chief Digital Officer Slawek Kierner and Director of Marketing, GI Digital Solutions Neviana Terzieva share their journeys into medtech and discuss how Olympus is integrating AI into endoscopy, clinical decision-making, and workflow optimization.  Chapter 1: Meet the Guests  Slawek Kierner and Neviana Terzieva discuss their backgrounds in software, healthcare, and digital innovation, and what drew them to Olympus.  Chapter 2: Defining AI in MedTech  What does “AI” really mean for medical devices?  How AI supports the quintuple aim: better outcomes, lower costs, improved experiences, increased access, and reduced burnout.  Chapter 3: Blended Intelligence & Burnout  The concept of “blended intelligence”-- AI as a complement to human expertise.  Chapter 4: Olympus® Technologies in Action  Spotlight on EDOF™ scopes, CADDIE™ polyp detection software, and the OLYSENSE™ platform.  Real-world examples of AI enhancing clarity, precision, and detection rates in GI procedures.  Chapter 5: Clinical Impact & Physician Reception  How AI augments, not replaces, clinical decision-making.  Physician perspectives on adopting new technology and maintaining high standards of care.  Chapter 6: The Future of AI at Olympus  Vision for saving lives, supporting detection rates, and empowering healthcare teams.   For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts.  This podcast has been paid for by Olympus Corporation of the Americas.    ADDITIONAL RESOURCES:  Meet OLYSENSE™ -- Olympus’ intelligent endoscopy platform powered by AI: https://medical.olympusamerica.com/olysense

In this episode of DeviceTalks Weekly, Host Tom Salem welcomes back Rob Kowal, MD, VP and general manager, cardiac pacing at Medtronic. You’ll hear how Dr. Kowal grew into the new role as business leader and gain a stronger appreciation for Medtronic’s flagship cardiac pacing business. Smaller devices and new innovation are helping to find new ways to deploy cardiac pacing. How else can cardiac pacing devices save lives? Dr. Kowal previously appeared on MedtronicTalks when he was vice president, medical affairs and CMO of cardiac rhythm and heart failure. Find the MedtronicTalks Podcast here - https://www.devicetalks.com/learn-how-medtronic-is-moving-to-mark-arctic-front-a-first-line-treatment-for-atrial-fibrillation/ Thank you to Confluent Medical Technologies for sponsoring this episode of DeviceTalks Weekly. To learn how their material science technologies and high performance manufacturing help bring your medical device designs to life go to ConfluentMedical.com or nitinol.com. MedTech Analyst Chrystal Larsen joins MassDevice Editor Chris Newmarker and Salemi on this week’s newsmakers. Before diving into the week’s top MedTech Stories, Larsen discusses the debut of MassDevice’s MedTech Market Reports on Continuous Glucose Monitoring (CGM) Market. You can find more information about the report here: https://www.massdevice.com/product/continuous-glucose-monitoring-cgm-market/  Top newsmakers of the week are Aqua Medical, Coherence Neuro, Medtronic, Smith & Nephew, and Zimmer Biomet. Thanks for listening to DeviceTalks Weekly. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - New DeviceTalks Podcast!(00:09:10) - New MassDevice Report(00:20:21) - MassDevice’s Newmarker’s Newsmakers(00:35:14) - Confluent Medical’s Impact on MedTech(00:37:47) - Keynote conversation with Rob Kowal, MD, VP and general manager, cardiac pacing, Medtronic

Empathy is more than a leadership trait—it’s a business advantage. In this season opener of Women in MedTech, host Kayleen Brown talks and Medtronic’s Nina Goodheart, SVP & President of Structural Heart & Aortic talk about Medtronic's focus on women's heart health and makes the business case for empathy in MedTech. Kayleen also welcomes Beth Harrison Meyer, SVP of Global Marketing at Aptyx, to unpack what empathy looks like inside companies and why it’s critical to innovation and culture. Thank you to Aptyx for your support. Visit ➡ https://www.aptyx.com Referenced in this episode: – Medtronic’s Letter to My Mother campaign: https://www.medtronic.com/en-us/c/patients-caregivers/pan-cardiovascular/letter-to-my-mother.html – Kayleen’s article in Medical Design & Outsourcing: https://www.medicaldesignandoutsourcing.com/medtronic-nina-goodheart-cardiovascular-deaths-women-rwe-smart-trial/ Enjoy this episode? Follow Women in MedTech → https://women-in-medtech.castos.com/subscribe and subscribe on YouTube → https://YouTube.com/@DeviceTalks to catch every conversation. #PurpleSuit Access the full DeviceTalks Podcast Network → https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Empathy to Self, Empathy to Ecosystem(00:02:45) - The Power of Mentorship and Sponsorship(00:05:30) - Building the Aptyx Culture of Collaboration(00:10:15) - Insights into the Keynote Interview with Nina Goodheartt(00:17:00) - What Empathy Looks Like in Product Development(00:22:15) - Designing for Equity: Who Are We Not Treating Yet?(00:27:10) - The Business Case for Empathy in MedTech(00:28:17) - Start of Interview with Medtronic's Nina Goodheart(00:36:30) - Using AI to Advance Health Equity (The ALERT Study)(00:49:30) - Medtronic's Letter to My Mother: Women’s Heart Health Awareness(00:55:15) - Redefining Leadership — Empathy as Smart Business

In this episode of DeviceTalks Weekly, Scott Miller, CEO of GE HealthCare’s Solutions for Enterprise Imaging, joins Managing Editor Kayleen Brown to explore how cloud technology and AI are transforming medical imaging. Miller discusses the launch of Genesis, GE HealthCare’s cloud-native imaging platform that enables secure data access, reduces clinician burnout, and improves efficiency across health systems. Together, they look ahead to a future of smarter, more connected care—where technology expands access, enhances collaboration, and supports truly personalized medicine for patients everywhere. But we’ll start off with MassDevice Editor Chris Newmarker’s Newsmakers – Zimmer Biomet, Tandem, Petal Surgical, Medline, Medtronic and the GREAT COMMONWEALTH of Massachusetts. Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:30) - Introducing this week’s keynote(00:08:56) - Zimmer Biomet wins FDA breakthrough nod for first iodine-treated hip replacement system(00:10:56) - Tandem launches t:slim X2 pump with Abbott FreeStyle Libre 3 Plus(00:13:15) - Incisionless surgical robotic tech startup Petal Surgical emerges from stealth with $10M Series A(00:15:30) - Medline officially files for IPO(00:17:12) - Medtronic gains millions in tax incentives for Massachusetts expansion(00:21:32) - Scott Miller, CEO of GE HealthCare’s Solutions for Enterprise Imaging

In this episode of AbbottTalks, hosts Tom Salemi and Kayleen Brown sit down with Dr. Finn Gustafsson, Chief Medical Officer for Abbott’s Heart Failure business, to discuss how Abbott’s technologies are transforming care across every stage of heart failure. Dr. Gustafsson—who spent decades in academic medicine before joining Abbott—explains how the company’s CentriMag™ System, HeartMate 3™ LVAD, and CardioMEMS™ HF System stabilize, sustain, and empower patients in each phase of the condition. The conversation explores what sets Abbott’s approach apart: early intervention through pulmonary artery pressure monitoring, mechanical circulatory support for critically ill patients, and long-term LVAD therapy that’s helping extend lives beyond five years. Lastly, Dr. Gustafsson shares insights from pivotal studies such as MOMENTUM 3, ARIES, and ASPIRE, which demonstrate how Abbott’s focus on evidence and patient experience is advancing the entire field. This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/ Thank you for listening to the AbbottTalks podcast! *** Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Exploring Abbott's Heart Failure Business and Digital Healthcare Innovation(00:03:36) - Transforming OEMs with Connectivity and Predictive Maintenance(00:05:54) - Dr. Finn Gustafsson's Journey from Academia to Abbott Heart Failure(00:11:20) - Understanding Heart Failure and Abbott's Heart Failure Portfolio(00:18:03) - Heart Monitoring Devices Enhance Patient Care and Empowerment(00:25:41) - AI-Driven Healthcare Innovation and Regulatory Navigation(00:29:20) - Advancements and Patient Impact of HeartMate 3 in Heart Failure(00:41:19) - Reducing Bleeding Risks in HeartMate 3 Patients Without Aspirin(00:42:45) - Advancements and Future Directions in LVAD Technology and Treatment(00:45:16) - Exploring MedTech Innovations and Patient Choices in Heart Devices

In this episode of DeviceTalks Weekly, Dr. Vishwa Srivastava shares his unique journey to leading one of the more dynamic surgical robotics companies in MedTech. Dr. Srivastava’s path takes him across disciplines and geographies from anthropology to medicine. He discusses the founding of SS Innovations, which has developed the Mantra series of surgical robotics systems that the company hopes can make a robotic surgery more accessible and affordable. Dr. Srivastava emphasizes the importance of telesurgery and the future of surgical robotics, highlighting the challenges and innovations in the field. Host Tom Salemi opens this episode with MassDevice Editor Chris Newmarker to review some of the top stories in MedTech over the past two weeks including – Olympus, Solventum, Boston Scientific, DePuy Synthes, and Hologic. Thank you for listening to DeviceTalks Weekly. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:07:23) - How Olympus views ‘different’ Swan EndoSurgical surgical robotics play(00:09:14) - Boston Scientific to acquire Nalu Medical for $533M(00:12:25) - Johnson & Johnson to separate DePuy Synthes Orthopaedics business(00:15:48) - Solventum hires Baxter EVP and COO Heather Knight for new C-suite role(00:18:26) - Hologic to be acquired by private equity firms Blackstone, TPG for up to $18.3B(00:25:22) - Keynote Interview, Vishwa Srivastava, MD - President & COO - South Asia(00:50:00) - Why did SS Innovations International need to be started.(01:09:00) - The case for surgical robotics(01:22:02) - Is telesurgery necessary?

In this episode of DeviceTalks Weekly, the DeviceTalks West on-site crew – Tom Salemi, Kayleen Brown, and Jim Hammerand – share their favorite moments and lessons of the two-day event. We’ll talk about keynotes, hot technologies, and the power of having and being a mentor. Thank you to our amazing sponsors, speakers, and attendees! Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

See how ambulatory endoscopy centers (AECs) are reshaping GI care—combining independent physicians’ personal investment with “nimble” innovation and improved patient access. In this episode, Olympus’ Director of Strategic Marketing for GI Diane Locher, joins Dr. Nalini Guda of GI Associates and Dr. Neil Parikh of CTGI & GI Alliance to discuss the unique challenges and opportunities of AECs. Learn how these centers streamline procedures, foster team-based care, and rapidly adopt new technologies, all while tackling access deserts and supporting physician well-being.  Chapter 1: Meet the Guests  Diane Locher shares her journey to Olympus and her focus on supporting AECs.  Dr. Nalini Guda and Dr. Neil Parikh introduce their backgrounds, independent practice models, and what drew them to GI.  Chapter 2: Defining AECs  What sets AECs apart from traditional ASCs and hospitals?  How “skin in the game” or independence drives efficiency, ownership, and patient-centered care.  The importance of nimbleness and adaptability in adopting new technologies.  Chapter 3: Access, Innovation, and Teamwork  Tackling “colonoscopy deserts” and improving patient access.  The team approach: physicians, nurses, anesthesiologists, and staff working toward a single goal.  How AECs serve as “innovation playgrounds” for piloting new GI technologies.  Chapter 4: Burnout, Well-being, and Technology  Physician burnout and how independent models help mitigate it.  The role of ambient listening and AI-powered documentation in streamlining workflow.  Training, onboarding, and staff support as critical components of AEC success.  Chapter 5: The Future of GI in AECs  Expanding the menu of procedures: from colorectal screening to endobariatrics and pancreaticobiliary care.  The evolving partnership between industry, physicians, and healthcare systems.  Advocacy and support to enable broader access.    For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts.  This podcast has been paid for by Olympus Corporation of the Americas. The views and experiences shared are those of Dr. Nalini Guda and Dr. Neil Parikh, paid consultants of Olympus Corporation and its affiliates. Olympus makes no representations regarding the accuracy or applicability of the content and disclaims all liability arising from its use. Product performance may vary, and techniques, instruments, and clinical decisions are unique to each facility and practitioner. Always refer to the Instructions for Use (IFU) and applicable labeling for guidance, risks, and cautions.  ADDITIONAL RESOURCES:  Take your AEC to the next level—partner with Olympus. Visit our site for training, resources, and portfolio solutions tailored to your needs. Visit, Ambulatory Surg...

In this episode of DeviceTalks Weekly, Dr. Steven Mickelsen shares his unique journey to becoming a leading figure in the MedTech industry. He discusses the evolution of pulse field ablation technology, the challenges faced in the field of electrophysiology, and his decision to start Field Medical, a follow up story to the historically successful Farapulse. Host Tom Salemi conducts the interview. This episode is sponsored by Viant. Managing Editor Kayleen Brown interviews Anthony Misener, GM, design and development, Viant. To learn more about Viant, visit https://viantmedical.com/. Sarah Matt, MD, a practicing physician, former tech exec, and now author sits in the virtual FOMO studio to give a sense of where Connected Health is headed. Dr. Matt will sit on a panel at DeviceTalks West exploring how deeply connected technologies have penetrated MedTech and the clinical setting. See Drs. Matt and Mickelsen at DeviceTalks West. Go to West.DeviceTalks.com to see the agenda. Thank you for listening to DeviceTalks Weekly. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:01:35) - Women in MedTech Breakfast Update(00:08:11) - Details Steven Mickelsen, MD’s talk at DeviceTalks West(00:13:00) - FOMO with Physician, Tech Guru and Author Sarah Matt, MD(00:25:26) - Anthony Misener, general manager, design and development, Viant(00:28:14) - Keynote Interview - Steven Mickelsen, MD, CEO of Field Medical

In this episode of DeviceTalks Weekly, Cognito Therapeutics’ Christian Howell conveys a deep sense of service that brought him to the MedTech industry. Host Tom Salemi talks with Howell about his Navy service, including a mission targeting pirates in the Persian Gulf on Sept. 11, 2001. From there, Howell gained a unique—and faraway—view of the tragic events that changed the world. He carried those lessons into roles at Covidien and Medtronic, where he helped drive Medtronic’s move into value-based healthcare. Howell is now leaning into that same call of service at Cognito Therapeutics, an MIT-launched startup working to prove that lights and sounds can stimulate the brain to slow the onset of dementia. The technology could become a platform for new brain therapeutics. You can learn more about Cognito’s technology at DeviceTalks West, where Chief Medical and Scientific Officer Ralph Kern will sit on a panel. Visit West.DeviceTalks.com for more information and to register. This week’s FOMO interview spotlights ivWatch, a new device for monitoring intravenous lines. MassDevice Editor Chris Newmarker delivers this week’s Newmarker’s Newsmakers, featuring CorWave, Medtronic, Olympus, Siemens Healthineers, and Zimmer Biomet. Thank you for listening to DeviceTalks Weekly. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of IntuitiveTalks, Host Tom Salemi visits Intuitive’s Atlanta hub to sit down with Brian Miller, executive vice president and chief digital officer.   Miller, who witnessed the first telesurgery procedure in 2001, shares his perspective on how surgical robotics has advanced beyond many early barriers to long-distance surgery. He emphasizes that adoption must be driven by user needs, not hype, with success hinging on meeting the daily realities of surgeons, patients, and health systems. This practical, patient-centered conversation explores what’s next for telesurgery.   This conversation comes to you courtesy of Blue Goat Cyber. To learn more, visit: https://bluegoatcyber.com/   *** Enjoy this podcast? Follow the DeviceTalks Podcast Network, home of IntuitiveTalks, on all major podcast players: https://devicetalks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an future episode.

In this episode of DeviceTalks Weekly, Managing Editor Kayleen Brown talks with Jyoti Gera, CEO of CardioVascular and Interventional Solutions for GE HealthCare, about her journey into the MedTech industry, the significance of cardiovascular health, the challenges faced in patient care, and the innovative solutions GE HealthCare is implementing to improve outcomes. Jyoti emphasizes the role of artificial intelligence in enhancing early detection and personalizing treatment, while also outlining the future of cardiology care as more connected and efficient. The conversation highlights the importance of collaboration in the healthcare ecosystem to address the growing burden of cardiovascular disease. This week’s FOMO guest Chris Steadham, vice president of technology at Aptyx, unpacks the evolution of implants and delivery systems. He emphasizes the importance of co-developing delivery systems alongside implants to ensure optimal performance and physician satisfaction. The discussion also touches on the impact of emerging technologies like AI and robotics in reshaping interventional procedures. For more information, go to https://aptyx.com/ Paul Grand, CEO of MedTech Innovator, commandeers the Newmarker’s Newsmakers to reveal the Finalists for MedTech Innovator’s finalists for its early-stage and execution awards. Read them here at MassDevice.https://www.massdevice.com/medtech-innovator-names-2025-grand-prize-finalists/ Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:04) - Keynote Interview with Jyoti Gera, CEO, CardioVascular & Interventional Solutions, GE HealthCare(00:02:45) - Welcome Paul Grand of MedTech Innovator(00:05:15) - MTI’s Execution Award Finalists(00:16:15) - MTI’s Early-stage Award Finalists(00:35:05) - FOMO with Chris Steadham, vice president, technology, Aptyx

In this episode of DeviceTalks Weekly, CMR Surgical CEO Massimiliano Colella joins Editorial Director Tom Salemi to share his wide-ranging journey through the MedTech industry. He talks about his experiences across global markets, his move from MedTech into the provider world, and why partnerships are critical to healthcare. Colella also dives into the future of surgical robotics, the importance of digital transformation, and CMR’s strategic vision moving forward. Sticking with the surgical robotics theme, our FOMO guest this week is Maggie Nixon, CEO of Capstan Medical, who sits down with Managing Editor Kayleen Brown. A big thanks to Vantedge Medical for sponsoring this episode of DeviceTalks Weekly. Learn more at https://vantedgemedical.com/ Be sure to catch Kayleen’s two-part interview with Cassandra Haupers, Director of Global Business Development, Machining at Vantedge Medical. (Want even more? Revisit their DeviceTalks West session from last year go to: https://event.on24.com/wcc/r/4612496/CCDA4762BD61D414E6C0DBC1D002216D?partnerref=DTWeekly .) Stick around for MassDevice’s Chris Newmarker’s Newsmakers listed in the timeline below. Thanks for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe   Episode rundown: 2:11 – Tom’s beef with Minnesota6:06 – Smith+Nephew reports positive clinical evidence for bioinductive implant8:39 – Dexcom CEO takes temporary leave of absence10:27 – Zimmer Biomet sues Deloitte for \$172M over ‘disaster’ project13:24 – Siemens Healthineers, Stryker partner on neurovascular robotics17:31 – Medtech Big 100: The world’s largest medical device companies23:00 – [Part 1] Cassandra Haupers, Director of Global Business Development, Machining, Vantedge Medical25:00 – FOMO – Maggie Nixon, Capstan Medical36:41 – Keynote – Massimiliano Colella, CMR Surgical55:58 – [Part 2] Cassandra Haupers, Vantedge Medical Chapters (00:02:11) - Tom’s beef with Minnesota(00:06:06) - Smith+Nephew reports positive clinical evidence for bioinductive implant(00:08:39) - Dexcom CEO takes temporary leave of absence(00:10:27) - Zimmer Biomet sues Deloitte for \$172M over ‘disaster’ project(00:13:24) - Siemens Healthineers, Stryker partner on neurovascular robotics(00:17:31) - Medtech Big 100: The world’s largest medical device companies(00:23:00) - [Part 1] Cassandra Haupers, Director of Global Business Development, Machining, Vantedge Medical(00:25:00) - FOMO – Maggie Nixon, Capstan Medical(00:36:41) - Keynote – Massimiliano Colella, CMR Surgical(00:55:58) - [Part 2] Cassandra Haupers, Vantedge Medical